Regeneron, Sanofi Get Positive CHMP Opinion for Dupixent

Date : 09/20/2019 @ 11:22AM
Source : Dow Jones News
Stock : Sanofi (SNY)
Quote : 47.07  1.12 (2.44%) @ 3:49PM

Regeneron, Sanofi Get Positive CHMP Opinion for Dupixent

Regeneron Pharmaceuticals (NASDAQ:REGN)
Historical Stock Chart

3 Months : From Aug 2019 to Nov 2019

Click Here for more Regeneron Pharmaceuticals Charts.

By Chris Wack


Regeneron Pharmaceuticals Inc. (REGN) and Sanofi (SNY) said Friday the European Medicines Agency's Committee for Medicinal Products for Human Use has adopted a positive opinion for Dupixent dupilumab in a third indication.

The companies said CHMP recommended Dupixent be approved as an add-on therapy with intranasal corticosteroids for the treatment of adults with severe chronic rhinosinusitis with nasal polyposis for whom therapy with systemic corticosteroids and/or surgery don't provide adequate disease control.

If approved, Dupixent would be the first biologic medicine available in the European Union to treat these patients.

Regeneron and Sanofi said the positive CHMP opinion is based on two pivotal Phase 3 trials that evaluated Dupixent 300 mg every two weeks plus standard-of-care intranasal corticosteroids compared to placebo plus intranasal corticosteroids. A final decision on the Dupixent application by the European Commission is expected in the coming months.


Write to Chris Wack at


(END) Dow Jones Newswires

September 20, 2019 07:07 ET (11:07 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Latest SNY Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.